Claudia Gallenstein
Acute Care · Huntsville, ALNPI 1710517867
Payments from drug & device makers
Across 97 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$506
- Merck$146
- Daiichi Sankyo Inc.$131
- Sanofi$125
- E.r. Squibb & Sons, L.L.C.$125
- Johnson & Johnson$113
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,490100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 15 | $506 |
| Merck | 6 | $146 |
| Daiichi Sankyo Inc. | 5 | $131 |
| Sanofi | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 7 | $125 |
| Johnson & Johnson(2 entities) | 6 | $113 |
| Genentech, Inc. | 1 | $102 |
| Novartis | 5 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| CSL Behring | 4 | $95 |
| Sobi, Inc | 3 | $84 |
| Stemline Therapeutics Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $67 |
| Pfizer | 3 | $64 |
| Incyte Corporation | 3 | $58 |
| AVEO Pharmaceuticals, Inc. | 3 | $54 |
| Beone Medicines USA, Inc. | 3 | $54 |
| Blueprint Medicines Corporation | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Eisai Inc. | 2 | $48 |
| Genentech USA, Inc. | 2 | $40 |
| AbbVie | 2 | $38 |
| Boehringer Ingelheim | 2 | $37 |
| Gilead | 2 | $37 |
| Puma Biotechnology, Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Immunocore Limited | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Bayer | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,490 in reported general payments places this provider in the 80th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Huntsville
- April KlarHuntsville$13K
- Stephanie TateHuntsville$13K
- Kelly VazquezHuntsville$12K
- Summer SlaterHuntsville$12K
- Tiffany RentzHuntsville$11K
- Britanie MooreHuntsville$9K
- Trey WilsonHuntsville$8K
- Esther HambrickHuntsville$8K
- Jessica BurkeenHuntsville$8K
- Alyssa EzellHuntsville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.